{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:51:08Z","timestamp":1792511468868,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["205184"],"award-info":[{"award-number":["205184"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015060","name":"Nagasaki University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009660","name":"London School of Hygiene and Tropical Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009660","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine: X"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jvacx.2023.100332","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T04:02:22Z","timestamp":1686888142000},"page":"100332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Cost-effectiveness analysis of maternal vaccination against Group B streptococcus in Japan"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9260-1000","authenticated-orcid":false,"given":"Sumire","family":"Sorano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0380-1503","authenticated-orcid":false,"given":"Simon R","family":"Procter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna C","family":"Seale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"February","key":"10.1016\/j.jvacx.2023.100332_b0005","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1093\/cid\/cix585","article-title":"Stillbirth with Group B Streptococcus Disease Worldwide: Systematic Review and Meta-analyses","volume":"65","author":"Seale","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.jvacx.2023.100332_b0010","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1093\/cid\/cix654","article-title":"Intrapartum antibiotic chemoprophylaxis policies for the prevention of group B streptococcal disease worldwide: systematic review","volume":"65","author":"Le Doare","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.jvacx.2023.100332_b0015","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1093\/cid\/cix655","article-title":"Risk of early-onset neonatal group B streptococcal disease with maternal colonization worldwide: systematic review and meta-analyses","volume":"65","author":"Russell","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.jvacx.2023.100332_b0020","doi-asserted-by":"crossref","first-page":"S200","DOI":"10.1093\/cid\/cix664","article-title":"Estimates of the burden of group B streptococcal disease worldwide for pregnant women, stillbirths, and children","volume":"65","author":"Seale","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.jvacx.2023.100332_b0025","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1093\/cid\/cix656","article-title":"Infant group B streptococcal disease incidence and serotypes worldwide: systematic review and meta-analyses","volume":"65","author":"Madrid","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.jvacx.2023.100332_b0030","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s10096-021-04396-y","article-title":"Epidemiology of group B streptococcal disease in infants younger than 1 year in Japan: a nationwide surveillance study 2016\u20132020","volume":"41","author":"Shibata","year":"2022","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"10.1016\/j.jvacx.2023.100332_b0035","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s15010-017-0995-2","article-title":"Group B streptococcal disease in infants in the first year of life: a nationwide surveillance study in Japan, 2011\u20132015","volume":"45","author":"Matsubara","year":"2017","journal-title":"Infection"},{"issue":"6","key":"10.1016\/j.jvacx.2023.100332_b0040","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S2352-4642(21)00022-5","article-title":"Mortality, neurodevelopmental impairments, and economic outcomes after invasive group B streptococcal disease in early infancy in Denmark and the Netherlands: a national matched cohort study","volume":"5","author":"Horv\u00e1th-Puh\u00f3","year":"2021","journal-title":"Lancet Child Adolesc Heal"},{"key":"10.1016\/j.jvacx.2023.100332_b0045","series-title":"Section of Obstetrics","year":"2020"},{"issue":"5","key":"10.1016\/j.jvacx.2023.100332_b0050","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0029-7844(96)00320-1","article-title":"The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery","volume":"88","author":"Yancey","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jvacx.2023.100332_b0055","unstructured":"Centers for Disease Control and Prevention (CDC). Perinatal group B streptococcal disease after universal screening recommendations--United States, 2003-2005. MMWR Morb Mortal Wkly Rep. 2007;56(28):701\u2013705. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17637595."},{"issue":"6","key":"10.1016\/j.jvacx.2023.100332_b0060","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.tjog.2019.09.014","article-title":"Variations in antibiotic susceptibility of group B Streptococcus in Japanese women: A long-term population-based cohort study","volume":"58","author":"Gomi","year":"2019","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.jvacx.2023.100332_b0065","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/22221751.2018.1557987","article-title":"Isolation of group B Streptococcus with reduced \u03b2-lactam susceptibility from pregnant women","volume":"8","author":"Moroi","year":"2019","journal-title":"Emerg Microbes Infect"},{"issue":"26","key":"10.1016\/j.jvacx.2023.100332_b0070","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1016\/j.vaccine.2015.12.072","article-title":"Status of vaccine research and development of vaccines for GBS","volume":"34","author":"Heath","year":"2016","journal-title":"Vaccine"},{"issue":"50","key":"10.1016\/j.jvacx.2023.100332_b0075","doi-asserted-by":"crossref","first-page":"7391","DOI":"10.1016\/j.vaccine.2017.09.087","article-title":"Maternal immunization against Group B streptococcus: World Health Organization research and development technological roadmap and preferred product characteristics","volume":"37","author":"Vekemans","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.jvacx.2023.100332_b0080","unstructured":"World Health Organization Preferred Product Characteristics for Group B Streptococcus Vaccines; 2017. https:\/\/www.who.int\/publications\/i\/item\/WHO-IVB-17.09."},{"issue":"46","key":"10.1016\/j.jvacx.2023.100332_b0085","doi-asserted-by":"crossref","first-page":"7033","DOI":"10.1016\/j.vaccine.2018.09.058","article-title":"Cost-effectiveness analysis of maternal immunisation against group B Streptococcus (GBS) disease: A modelling study","volume":"36","author":"Giorgakoudi","year":"2018","journal-title":"Vaccine"},{"issue":"17","key":"10.1016\/j.jvacx.2023.100332_b0090","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.vaccine.2014.01.062","article-title":"Cost-effectiveness of a potential group B streptococcal vaccine program for pregnant women in South Africa","volume":"32","author":"Kim","year":"2014","journal-title":"Vaccine"},{"issue":"45","key":"10.1016\/j.jvacx.2023.100332_b0095","doi-asserted-by":"crossref","first-page":"6238","DOI":"10.1016\/j.vaccine.2017.08.085","article-title":"Cost-effectiveness of a potential group B streptococcal vaccine for pregnant women in the United States","volume":"35","author":"Kim","year":"2017","journal-title":"Vaccine"},{"issue":"49 Pt B","key":"10.1016\/j.jvacx.2023.100332_b0100","doi-asserted-by":"crossref","first-page":"6905","DOI":"10.1016\/j.vaccine.2017.07.108","article-title":"Cost-effectiveness of maternal GBS immunization in low-income sub-Saharan Africa","volume":"35","author":"Russell","year":"2017","journal-title":"Vaccine"},{"issue":"37","key":"10.1016\/j.jvacx.2023.100332_b0105","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1016\/j.vaccine.2014.06.003","article-title":"Prevention of group B streptococcal disease in the first 3 months of life: would routine maternal immunization during pregnancy be cost-effective?","volume":"32","author":"Oster","year":"2014","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.jvacx.2023.100332_b0110","doi-asserted-by":"crossref","first-page":"e1004068","DOI":"10.1371\/journal.pmed.1004068","article-title":"Maternal immunisation against Group B Streptococcus: A global analysis of health impact and cost-effectiveness","volume":"20","author":"Procter","year":"2023","journal-title":"PLOS Med"},{"key":"10.1016\/j.jvacx.2023.100332_b0115","unstructured":"Matsuda R. International Health Care System Profiles, Japan. The Commonwealth Fund. Published 2020. https:\/\/www.commonwealthfund.org\/international-health-policy-center\/countries\/japan."},{"issue":"4","key":"10.1016\/j.jvacx.2023.100332_b0120","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/13696998.2020.1716775","article-title":"Health technology assessment in Japan: a work in progress","volume":"23","author":"Kamae","year":"2020","journal-title":"J Med Econ"},{"key":"10.1016\/j.jvacx.2023.100332_b0125","unstructured":"Ministry of Health Labor and Welfare. Vital statistics 2019. Published 2021. Accessed April 7, 2023. https:\/\/www.mhlw.go.jp\/toukei\/saikin\/hw\/jinkou\/kakutei19\/dl\/03_h1.pdf."},{"issue":"Suppl 2","key":"10.1016\/j.jvacx.2023.100332_b0130","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1093\/cid\/cix661","article-title":"Preterm birth associated with group B streptococcus maternal colonization worldwide: systematic review and meta-analyses","volume":"65","author":"Bianchi-Jassir","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jvacx.2023.100332_b0135","unstructured":"Center for Outcomes Research and Economic Evaluation for Health. Guideline for Preparing Cost-Effectiveness Evaluation to the Central Social Insurance Medical Council Version 2.0.; 2019. Accessed April 7, 2023, https:\/\/c2h.niph.go.jp\/tools\/guideline\/guideline_en.pdf."},{"issue":"12","key":"10.1016\/j.jvacx.2023.100332_b0140","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1093\/cid\/ciy838","article-title":"A phase 2, randomized, control trial of group B streptococcus (GBS) type III capsular polysaccharide-tetanus toxoid (GBS III-TT) vaccine to prevent vaginal colonization with GBS III","volume":"68","author":"Hillier","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jvacx.2023.100332_b0145","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0887-8994(96)00024-0","article-title":"Epidemiology of bacterial meningitis in children: Aichi prefecture, Japan, 1984\u20131993","volume":"14","author":"Ishikawa","year":"1996","journal-title":"Pediatr Neurol"},{"issue":"Suppl 2","key":"10.1016\/j.jvacx.2023.100332_b0150","doi-asserted-by":"crossref","first-page":"S190","DOI":"10.1093\/cid\/cix663","article-title":"Neurodevelopmental impairment in children after group B streptococcal disease worldwide: systematic review and meta-analyses","volume":"65","author":"Kohli-Lynch","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jvacx.2023.100332_b0155","unstructured":"Ministry of Health Labor and Welfare. Simple life table 2020. Accessed April 7, 2023, https:\/\/www.e-stat.go.jp\/stat-search\/files?page=1&layout=datalist&toukei=00450012&tstat=000001031336&cycle=7&tclass1=000001060864&tclass2=000001163166&tclass3val=0."},{"issue":"6","key":"10.1016\/j.jvacx.2023.100332_b0160","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1471-0528.2005.00555.x","article-title":"Cost-effectiveness of different treatment strategies with intrapartum antibiotic prophylaxis to prevent early-onset group B streptococcal disease","volume":"112","author":"Akker-van Marle","year":"2005","journal-title":"BJOG"},{"key":"10.1016\/j.jvacx.2023.100332_b0165","unstructured":"Ministry of Health Labor and Welfare. Survey Report on Vaccination Fee in Japan. 2012, Accessed 7, 2023, https:\/\/www.mhlw.go.jp\/file\/05-Shingikai-10601000-Daijinkanboukouseikagakuka-Kouseikagakuka\/0000032800.pdf."},{"key":"10.1016\/j.jvacx.2023.100332_b0170","unstructured":"Ministry of Health Labor and Welfare. Fee of Medical Service Payment System 2020. Published 2020. Accessed August 11, 2021. https:\/\/clinicalsup.jp\/contentlist\/shinryo\/ika\/index.html."},{"key":"10.1016\/j.jvacx.2023.100332_b0175","unstructured":"Ministry of Health Labor and Welfare. Medical Benefit Survey 2017. Published 2019. Accessed April 7, 2023. https:\/\/www.e-stat.go.jp\/stat-search\/files?page=1&layout=datalist&toukei=00450389&tstat=000001044924&cycle=0&tclass1=000001044945&tclass2=000001132104."},{"issue":"4","key":"10.1016\/j.jvacx.2023.100332_b0180","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/hec.1481","article-title":"International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness?","volume":"19","author":"Shiroiwa","year":"2010","journal-title":"Health Econ"},{"key":"10.1016\/j.jvacx.2023.100332_b0185","unstructured":"Japan Society of Obstetrics and Gynecology. Perinatal Statistics 2019; 2020. Accessed April 7, 2023, https:\/\/www.jsog.or.jp\/modules\/committee\/index.php?content_id=8."},{"issue":"6","key":"10.1016\/j.jvacx.2023.100332_b0190","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/bioe.12120","article-title":"Valuing stillbirths","volume":"29","author":"Phillips","year":"2015","journal-title":"Bioethics"},{"issue":"1","key":"10.1016\/j.jvacx.2023.100332_b0195","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jval.2021.07.009","article-title":"A pregnant pause: Rethinking economic evaluation in contraception and pregnancy","volume":"25","author":"Abel","year":"2022","journal-title":"Value Heal"},{"key":"10.1016\/j.jvacx.2023.100332_b0200","unstructured":"Kobe City. Survey on situation of children with severe mental and physical disabilities; 2019. https:\/\/www.city.kobe.lg.jp\/documents\/30690\/3-1zyusyousinsinsyougaizisyazittaityousa.pdf."}],"container-title":["Vaccine: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136223000736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136223000736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:26:31Z","timestamp":1792509991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590136223000736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":40,"alternative-id":["S2590136223000736"],"URL":"https:\/\/doi.org\/10.1016\/j.jvacx.2023.100332","relation":{},"ISSN":["2590-1362"],"issn-type":[{"value":"2590-1362","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness analysis of maternal vaccination against Group B streptococcus in Japan","name":"articletitle","label":"Article Title"},{"value":"Vaccine: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvacx.2023.100332","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100332"}}